Abdullah Karaer | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Abdullah Karaer | Molecular Biology | Best Researcher Award 

Researcher, at Inonu University School of Medicine, Turkey.

Prof. Dr. Abdullah Karaer is a distinguished Turkish physician-scientist specializing in reproductive endocrinology and infertility. Born in 1977, he currently serves as Professor of Obstetrics & Gynecology at Inonu University, where he is also the Head of the IVF Unit and the Department of Obstetrics & Gynaecology. He founded and leads the Reproductive Sciences and Bioinformatics Research and Application Center at the same institution. With over two decades of experience, Dr. Karaer has contributed significantly to women’s health, fertility, and biomedical research. He integrates clinical expertise with advanced bioinformatics and omics technologies to tackle complex reproductive challenges. An active educator and mentor, he continues to shape the next generation of clinicians and scientists. His work has earned over 1000 citations, and his leadership in numerous interdisciplinary projects cements his role as a leading figure in reproductive medicine and academic innovation. 🌐🧪

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Prof. Dr. Abdullah Karaer’s educational journey is a testament to his commitment to lifelong learning and interdisciplinary excellence. He earned his M.D. from Ankara University in 2001 and completed his specialization in Obstetrics & Gynaecology in 2007, defending a thesis on Y chromosome microdeletions in recurrent pregnancy loss. In 2022, he embarked on a PhD program in Stem Cells and Regenerative Medicine at Ankara University’s Stem Cell Institute, reflecting his interest in cutting-edge medical biotechnology. In 2024, he pursued an Associate’s degree in Computer Programming at Ankara University, signaling his commitment to bioinformatics and digital health. His solid grounding in clinical medicine, coupled with continuous academic development in genomics and informatics, uniquely positions him to lead translational research in reproductive sciences. 🧠📚💻

💼 Experience 

Dr. Karaer’s career spans clinical excellence, academic leadership, and pioneering research. Since 2018, he has served as Professor of Obstetrics & Gynecology at Inonu University, where he also leads the IVF Unit and the Division of Reproductive Endocrinology & Infertility. He founded the Reproductive Sciences and Bioinformatics Research and Application Center in 2019. Previously, he held roles as Associate Professor (2013–2018) and Assistant Professor (2010–2013) at the same university. His early clinical career includes posts at Merzifon Air Military Hospital and Siirt Women’s Health & Children Hospital. A dedicated educator, he mentors students at undergraduate and graduate levels, contributes to national medical education boards, and leads thesis supervision for future medical experts. His integration of patient care with translational research and data-driven solutions has set benchmarks in Turkey’s reproductive medicine landscape. 🏥📈👨‍🏫

🔬 Research Interest 

Prof. Karaer’s research is deeply rooted in reproductive sciences, with a focus on infertility, polycystic ovary syndrome (PCOS), endometriosis, oocyte quality, and assisted reproductive technologies. He harnesses multi-omics techniques—including metabolomics, transcriptomics, and metagenomics—to decode complex biological systems affecting fertility. His work examines the molecular underpinnings of follicular fluid composition, cumulus cell gene expression, and the impact of the vaginal microbiome on IVF outcomes. His interdisciplinary projects incorporate bioinformatics, proteomics, and advanced imaging, making his lab a hub for integrative reproductive biology. As a principal investigator in nationally and internationally funded studies, he collaborates on projects related to PCOS-related endometrial cancer, idiopathic male infertility, and placental pathophysiology in preeclampsia. Dr. Karaer’s innovative approach bridges bench-to-bedside research, aiming to enhance patient outcomes through precision reproductive medicine. 🧫🧬🧠

🏆 Awards 

Prof. Karaer’s career reflects a dedication to scientific excellence and public health impact. While formal award listings are not provided in this record, his leadership roles, continuous academic promotions, and invitations to lead national research projects attest to his recognition as an influential expert in reproductive medicine. He has served on national boards such as the National Medicine Specialty Board in Obstetrics & Gynecology and has been a key member of societies like the European Society of Human Reproduction and Embryology. His ongoing projects funded by TÜBİTAK, TÜSEB, and COST-EU illustrate the high level of trust and investment from both national and international scientific bodies. These honors underscore his capability to lead large-scale, multi-omics, and translational medical research projects addressing fertility and reproductive health. 🏅🌍📖

📚 Top Noted Publications

Dr. Karaer is the author of 65 scientific publications, cited over 1,095 times (Scopus) and 1,922 times (Google Scholar), with an h-index of 19 and 24 respectively. His studies appear in top-tier journals like BJOG, Andrology, Journal of Assisted Reproduction and Genetics, and Fertility and Sterility. His work spans vaginal microbiota, seminal and follicular fluid metabolomics, gene expression in cumulus cells, and endometriosis-related fertility outcomes. Notable publications include:

1. The Vaginal Microbiota Composition of Women Undergoing Assisted Reproduction

  • Journal: BJOG: An International Journal of Obstetrics & Gynaecology

  • Publication Year: 2021

  • Study Type: Prospective cohort study

  • Objective: To investigate the vaginal microbiota composition in women undergoing assisted reproduction and its potential impact on reproductive outcomes.

  • Key Findings: The study identified specific vaginal microbiota profiles associated with reproductive success, suggesting that certain microbial compositions may influence the outcomes of assisted reproductive technologies.

  • Link: PubMed Abstract

2. Metabolomics Analysis of Seminal Plasma in Patients with Idiopathic Oligoasthenoteratozoospermia Using High-Resolution NMR Spectroscopy

  • Journal: Andrology

  • Publication Year: 2020

  • Authors: A. Mumcu, A. Karaer, B. Dogan, G. Tuncay

  • Objective: To determine whether metabolites could serve as potential biomarkers for diagnosing male factor infertility by comparing seminal plasma samples from infertile men with oligoasthenoteratozoospermia (OAT) to those from normozoospermic controls.

  • Key Findings: The study found significant differences in metabolite levels between the two groups, with decreased levels of lactate, citrate, lysine, arginine, valine, glutamine, creatinine, α-ketoglutaric acid, spermine, and putrescine in OAT patients. Tyrosine levels were increased. The PLS-DA model achieved 89.29% sensitivity and 93.55% specificity in distinguishing between the groups.

  • Link: Wiley Online LibraryWiley Online Library

3. The Effect of Seminal Plasma Cadmium and Lead Levels on Semen Parameters in Male Subjects of Infertile Couples: A Prospective Cohort Study

  • Journal: Journal of Obstetrics and Gynaecology

  • Publication Year: 2020

  • Authors: Gorkem Tuncay, Abdullah Karaer, Emrullah Tanrikut, Onur Ozgul

  • Objective: To investigate the relationship between seminal plasma cadmium (Cd) and lead (Pb) levels and semen parameters in male partners of infertile couples.

  • Key Findings: Cadmium levels were significantly higher in men with hypospermia compared to those with normal semen volume (p = .049). No significant differences were observed in lead levels or other semen parameters. The findings suggest that environmental cadmium exposure may contribute to low semen volume.

  • Link: Taylor & Francis OnlineTaylor & Francis Online+1PubMed+1

4. Follicular Fluid Metabolomics in Maternal Aging

  • Journal: Journal of Assisted Reproduction and Genetics (JARG)

  • Publication Year: 2020

  • Objective: To analyze the metabolomic profile of follicular fluid in relation to maternal aging and its impact on oocyte quality and fertility.

  • Key Findings: The study identified age-related changes in the follicular fluid metabolome, suggesting that alterations in specific metabolites may affect oocyte competence and reproductive outcomes in older women.

  • Link: PubMed Abstract

5. Microarray Analysis in Endometriosis

  • Journal: Journal of Endometriosis and Pelvic Pain Disorders (JEPPD)

  • Publication Year: 2020

  • Objective: To utilize microarray analysis to identify gene expression patterns associated with endometriosis.

  • Key Findings: The study revealed specific gene expression profiles in endometrial tissues of patients with endometriosis, providing insights into the molecular mechanisms underlying the disease and potential targets for therapy.

  • Link: PubMed Abstract

Conclusion

Professor Abdullah Karaer is highly suitable for the Best Researcher Award. His multidisciplinary approach, consistent research productivity, leadership in reproductive and bioinformatics research, and proven mentorship make him a standout candidate. With minor enhancements in international engagement and digital presence, his profile would reach even greater global competitiveness.

Weiwei Fu | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr. Weiwei Fu | Molecular Biology | Best Researcher Award 

Research assistant professor, at Peking University Third Hospital, China.

Dr. Fu Weiwei is an accomplished medical scientist specializing in gastroenterology and immunology. She currently serves as an Assistant Research Professor and Laboratory Director at the Gastroenterology Department, Peking University Third Hospital, where she leads research at the Beijing Key Laboratory. Dr. Fu earned her Ph.D. in Immunology from Peking University Health Science Center and has a strong foundation in traditional medicine, holding a Bachelor of Medicine from Shandong University. With more than a decade of experience in translational medical research, her work bridges cutting-edge immunological discoveries and practical clinical applications. Her focus lies in immune microenvironment dynamics, gastrointestinal tumor evolution, and the integration of traditional Chinese medicine for digestive disease therapies. She has delivered several high-profile international presentations and has published widely in leading scientific journals. Her contributions have significantly advanced the field of digestive immunology.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Fu’s academic journey began with a 5-year Bachelor of Medicine program at Shandong University of Traditional Chinese Medicine (2002–2007), where she laid a solid foundation in both conventional and traditional healthcare practices. Her early exposure to integrative medicine inspired a unique perspective on digestive health and immune response. Motivated by scientific rigor, she enrolled in the Combined Master’s and Ph.D. Program in Immunology (2008–2013) at Peking University Health Science Center, mentored by Prof. Wenling Han. This elite program sharpened her skills in molecular biology, immunopathology, and clinical translational research. Throughout her doctoral years, she focused on the host immune responses in cancer, particularly those related to gastric inflammation and tumorigenesis. This diverse academic training enables her to merge modern biomedical technologies with traditional insights, giving her an edge in the multidisciplinary field of digestive immunology.

🧪 Experience

Dr. Fu brings a wealth of research and clinical experience to her current position at the Gastroenterology Department, Peking University Third Hospital (2019–present), where she directs the Beijing Key Laboratory. As an Assistant Research Professor, she leads a team focusing on translational immunology in gastrointestinal diseases. Before this, she completed a prestigious postdoctoral fellowship (2013–2019) at the Tsinghua University Institute of Immunology under Prof. Chen Dong, an Academician of the Chinese Academy of Sciences. During this time, she worked on T-cell signaling, immune checkpoints, and the role of lymphoid cells in cancer. Her lab currently integrates clinical cohort data with multi-omics techniques to explore disease mechanisms. She is also instrumental in mentoring junior researchers and clinicians. Her work bridges laboratory immunology with bedside applications, ensuring scientific advancements are translated into improved diagnosis and therapy for patients.

🔬 Research Interests

Dr. Fu’s research centers on the immune microenvironment in gastrointestinal tumors and digestive tract diseases, such as gastric cancer and inflammatory bowel disease. She applies multi-omics technologies—including single-cell RNA sequencing, proteomics, and microbiome analysis—to decipher host-pathogen interactions and immune cell dynamics during disease evolution. A key aspect of her research is understanding how Helicobacter pylori infection initiates gastric lesions, tumor progression, and immune escape. She also investigates traditional Chinese medicine-based therapies, exploring their role in cancer prevention and immune modulation. Another focal point is early screening and biomarker discovery for precancerous lesions through clinical cohort studies. By integrating high-throughput data with clinical insights, her work aims to improve patient stratification and individualized treatments. Her interdisciplinary approach bridges immunology, oncology, and traditional medicine, placing her at the forefront of gastrointestinal research in China and beyond.

🏆 Awards

Dr. Fu’s scientific excellence has been consistently recognized. She won the Outstanding Paper Award at the 2023 Chinese Medical Association’s National Conference on Digestive Diseases (CGC 2023) for her oral presentation on immune profiling during colorectal cancer progression. Her continuous contributions to clinical immunology, translational oncology, and molecular diagnostics have earned her accolades from both national and international platforms. Her selection as an oral presenter at leading conferences—such as DDW 2024 in Washington, D.C., and UEGW 2023 in Copenhagen—speaks to her international recognition. She has also received patent grants for innovations in inflammation and cancer therapy, reflecting her drive for practical applications. As a dedicated researcher, educator, and innovator, Dr. Fu stands out as a top candidate for award nominations in the fields of biomedical research and clinical translational science.

📚 Top Noted Publications

Dr. Fu has authored and co-authored numerous impactful papers in top-tier journals (JCR Q1–Q3), often as first or corresponding author. Below are select publications with hyperlink.

2025

  1. Luteolin Improves Precancerous Gastric Mucosa by Binding STAT3
    International Journal of Biological Sciences (Q1, IF 8.1)
    📌 Co-Corresponding Author
    🧪 Original Research

  2. CMTM3 Regulates Colitis-Associated Cancer Progression
    Cellular and Molecular Gastroenterology and Hepatology (CMGH) (Q1, IF 7.1)
    📌 Co-Corresponding Author
    🧬 Original Research

  3. Cmtm4 Deficiency Exacerbates H. pylori-Induced Gastric Carcinogenesis
    Pathology International (Q2, IF 2.5)
    📌 Co-Corresponding Author
    🦠 Original Research

  4. The Host Immune Response Landscape in Gastric Cancer Development
    Clinical and Experimental Immunology (Q2, IF 3.4)
    📌 First Author
    🧫 Original Research

2024

  1. Neutrophil Heterogeneity in Hepatocellular Carcinoma and Tumor Immunity
    Cancer Medicine (Q2, IF 2.9)
    📌 Co-First Author
    🔬 Original Research

  2. Oxidative Balance in Diet and Sleep Patterns: A Metabolic Interaction
    Frontiers in Nutrition (Q2, IF 4.0)
    📌 Co-First Author
    🍽 Original Research

  3. CMTM4 Facilitates Gastric Cancer Metastasis via EMT Modulation
    Journal of Gastrointestinal Oncology (Q3, IF 2.0)
    📌 Co-First Author
    🧠 Original Research

  4. Cmtm4 Shapes Colitis Outcomes via Microbial Dysbiosis and Mucosal Immunity
    Journal of Genetics and Genomics (Q1, IF 6.6)
    📌 Co-Corresponding Author
    🧪 Original Research

  5. Serum Proteomics-Based Biomarkers of Precancerous Gastric Lesions
    Frontiers in Molecular Biosciences (Q2, IF 3.9)
    📌 Co-Corresponding Author
    🔍 Original Research

  6. Treg Subsets Orchestrate Tumor Microenvironment in Colorectal Cancer
    Frontiers in Immunology (Q1, IF 5.7)
    📌 Co-First & Corresponding Author
    🧫 Original Research

2023

  1. Helicobacter pylori and Inflammasome Activation in Gastric Pathogenesis (Review)
    Helicobacter (Q2, IF 4.3)
    📌 Co-Corresponding Author
    🧯 Review Article

2022

  • Lymphocyte Profile Alterations in Precancerous Gastric Lesions
    Journal of Leukocyte Biology (Q2, IF 5.5)
    📌 First Author
    🧬 Original Research

  • B7 Family Molecules and Immune Evasion in H. pylori Infection (Review)
    Helicobacter (Q2, IF 4.4)
    📌 Co-Corresponding Author
    🧫 Review Article

Conclusion

Dr. FU Weiwei demonstrates an exceptional and well-rounded profile as a medical researcher with significant contributions to immunology and gastroenterology, supported by prestigious academic training, a robust scientific publication record, impactful patents, and strong conference presence. These achievements, particularly in translational cancer immunology, make Dr. Fu highly suitable for the Best Researcher Award.

Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award

Posted on by sciencefather

Prof. Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award 

Associate Professor, at Tehran University of Medical Sciences, Iran.

Dr. Somayeh Ebrahimibarough is an accomplished biomedical researcher specializing in regenerative medicine, tissue engineering, and stem cell biology. She holds a Ph.D. in Cell and Developmental Biology and is currently a Research Professional 5 at the University of Minnesota’s Department of Biomedical Engineering. Her research focuses on human iPSC-derived cardiac organoids, with a particular interest in extracellular matrix (ECM) effects on cardiomyocyte differentiation. With extensive expertise in mass spectrometry-based proteomics, cardiac tissue engineering, and stem cell-based therapies, Dr. Ebrahimibarough has also contributed significantly to peripheral nerve regeneration and stem cell-derived cancer treatments. She has experience in GMP-compatible cell manufacturing, ensuring the safe development of tissue-specific stem cell transplantation strategies for clinical applications. As a dedicated interdisciplinary researcher, she collaborates on cutting-edge studies in cardiac regeneration and disease modeling, advancing the frontiers of biomedical science.

Professional Profile

Google Scholar

🎓 Education

Dr. Somayeh Ebrahimibarough has a strong academic background in biology and regenerative medicine. She earned her Ph.D. in Developmental Biology from Kharazmi University (2008–2013), where she specialized in stem cell differentiation and regenerative therapies. Before that, she completed her M.S. in Cell and Developmental Biology at Kharazmi University (2006–2008) and a B.S. in Biology from Mohaghegh Ardabili University (2002–2005). She later pursued a Postdoctoral Fellowship in Tissue Engineering and Regenerative Medicine at Tehran University of Medical Sciences (2013–2015). Throughout her education, she has focused on stem cell applications, biomaterials, and molecular biology, which have shaped her career in biomedical research and tissue engineering.

💼 Experience

Dr. Ebrahimibarough has a diverse professional background in biomedical research and biotechnology. She is currently a Research Professional 5 at the University of Minnesota (2024–present), investigating ECM effects on cardiomyocyte differentiation in iPSC-derived cardiac organoids. Previously, she was a faculty member at Tehran University of Medical Sciences (2015–2024), where she led research on stem cell-based therapies, exosome treatments, and neural tissue engineering. She has also served as a Production Manager at Inocells Company in the Netherlands (2019–2023), overseeing infertility treatment projects using mesenchymal stem cells under GMP conditions. Her extensive experience in stem cell biology, tissue engineering, and regenerative medicine has positioned her as a leader in the field, contributing to groundbreaking research in cell-based therapies and biomaterials.

🔬 Research Interests

Dr. Ebrahimibarough’s research interests lie at the intersection of regenerative medicine, tissue engineering, and stem cell biology. She is particularly focused on human iPSC-derived cardiac organoids, studying the extracellular matrix’s role in cardiomyocyte differentiation. Her work also extends to biomaterials and tissue scaffolds for nerve regeneration, with an emphasis on injectable hydrogels, electrospun scaffolds, and decellularized matrices. Additionally, she is engaged in mass spectrometry-based proteomics, analyzing cellular signaling pathways and extracellular matrix components. Dr. Ebrahimibarough is passionate about GMP-compliant cell manufacturing and clinical translation of stem cell therapies, developing strategies for tissue-specific stem cell transplantation. Her interdisciplinary approach integrates bioengineering, molecular biology, and translational medicine, aiming to advance therapeutic applications in cardiac and neural regeneration.

🏆 Awards & Recognitions

Dr. Ebrahimibarough has received several prestigious awards for her contributions to biomedical research:

  • One-Year Salary Grant for Postdoctoral Research (2014) – Awarded by the Iran National Science Foundation (INSF) for excellence in tissue engineering research.
  • Research Excellence Program Grant (2017) – Recognized by USC–IRAN (Spain) for outstanding contributions to stem cell-based regenerative medicine.
  • Educated Researcher Award (2018) – Received from the National Institute for Medical Research Development (NIMAD), Iran, honoring her groundbreaking work in biomedical sciences.

Her awards reflect her dedication to advancing regenerative medicine and translational research, impacting the fields of tissue engineering and stem cell therapy.

📚 Top Noted Publications

Dr. Ebrahimibarough has published extensively in high-impact journals, contributing to the advancement of biomedical research. Here are some of her key publications:

  • Tissue Engineering and Stem Cell-Based Therapeutic Strategies for Premature Ovarian Insufficiency
    This review addresses the potential of tissue engineering and stem cell therapies in treating premature ovarian insufficiency (POI). It discusses various stem cell sources and biomaterials that can restore ovarian function, highlighting the challenges and ethical considerations in developing these therapeutic strategies.

    PubMed

  • Cell-Free Therapy Based on Extracellular Vesicles
    This article explores the application of exosome-based therapies as a promising approach for nerve regeneration and functional recovery. It emphasizes the role of mesenchymal stem cell-derived exosomes in overcoming challenges associated with cell-based therapies for peripheral nerve injuries.

    PubMed Central

  • Embryonic Stem Cells Differentiated into Neuron-Like Cells Using SB431542 on Nanofibrous Scaffolds
    The study investigates the differentiation of embryonic stem cells into neuron-like cells using the small molecule SB431542 on nanofibrous scaffolds composed of polylactic acid (PLA), chitosan (CS), and wax. The findings suggest that this combination enhances neural differentiation, offering potential in neural tissue engineering applications.

    experts.umn.edu

  • Cell-Based Therapy for Spinal Muscular Atrophy
    This research focuses on the potential of cell-based therapies in treating spinal muscular atrophy (SMA). It evaluates the efficacy of various stem cell types in restoring motor function and highlights the challenges in translating these therapies into clinical practice.

    experts.umn.edu

  • Stimulation of Osteogenic Differentiation of Induced Pluripotent Stem Cells Using Bioactive Glasses
    The study examines the effect of bioactive glasses on the osteogenic differentiation of induced pluripotent stem cells (iPSCs). The results indicate that bioactive glasses can effectively stimulate iPSCs to differentiate into osteoblast-like cells, suggesting their potential in bone tissue engineering.

    frontiersin.org

  • Preparation of Bilayer Tissue-Engineered Polyurethane/Poly-L-Lactic Acid Vascular Grafts
    This research involves the development of bilayered vascular grafts using polyurethane and poly-L-lactic acid. The study assesses the grafts’ mechanical properties and biocompatibility, indicating their potential application in vascular tissue engineering.

    Journal of Biological Engineering

Conclusion

Dr. Somayeh Ebrahimibarough is a highly qualified and impactful researcher in biomedical engineering, regenerative medicine, and stem cell biology. Her strong publication record, global research collaborations, and technical expertise make her a top contender for a Best Researcher Award. To further strengthen her case, securing high-profile grants, increasing industry collaborations, and enhancing leadership roles in global biomedical communities could be beneficial.

Alexander Shirokov | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr. Alexander Shirokov | Molecular Biology | Best Researcher Award 

Senior Researcher at the Laboratory of Immunochemistry, at Ibppm ras, Russia.

Dr. Shirokov Alexander Alexandrovich, Ph.D., is an esteemed Associate Professor specializing in microbiology and immunochemistry. He serves as a Senior Researcher at the Laboratory of Immunochemistry and heads the Center for Collective Use “Symbiosis” at the Institute of Biochemistry and Physiology of Plants and Microorganisms (IBPPM) of the Russian Academy of Sciences. Additionally, he leads the Central Research Center at Saratov National Research State University. Dr. Shirokov’s research spans antigens, cell biology, and optical technologies, with a focus on glioblastoma and brain vascular systems. His extensive involvement in educational and public activities, including mentoring students and chairing scientific conferences, highlights his dedication to advancing scientific knowledge and nurturing young talent. Recognized for his contributions to science, Dr. Shirokov has received prestigious awards and continues to drive innovation in immunochemical and biotechnological research.

Profile

Scopus

ORCID

🎓 Education

Dr. Shirokov earned his Specialist degree in Organic and Bioorganic Chemistry from Saratov State University (1999–2004). He pursued postgraduate studies in Microbiology (specialty 03.02.03) at the Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (2004–2008), where he earned his Candidate of Biological Sciences (Ph.D.). His academic focus encompassed microbiology, biochemistry, and biotechnology. This solid educational foundation equipped him with expertise in immunochemistry, confocal microscopy, and cell biology. Dr. Shirokov’s teaching contributions include specialized courses on aerobiology and light microscopy. He has supervised numerous diploma projects and postgraduate theses, demonstrating a strong commitment to academic mentorship and research excellence.

👨‍💼 Experience

Dr. Shirokov has held multiple distinguished positions in academia and research. Since 2020, he has been a Senior Researcher at the Smart Sleep Laboratory and Head of the Central Research Center at Saratov National Research State University. Concurrently, he serves as a Senior Researcher and Center Head at IBPPM, focusing on immunochemistry and biotechnology. His leadership extends to mentoring students, managing diploma projects, and supervising postgraduate research. He has organized national scientific conferences and contributed to regional scientific councils, shaping policy and fostering young scientists. His career is marked by collaboration on high-impact projects in brain research, immunotherapy, and biotechnological innovation, enhancing our understanding of complex biological systems and their medical applications.

🔬 Research Interests 

Dr. Shirokov’s research spans immunochemistry, cell biology, and biotechnology. His primary focus areas include antigen characterization, glioblastoma research, and the vascular and lymphatic systems of the brain. Utilizing advanced techniques like confocal and electron microscopy, he explores cellular structures and immune responses. His work on brain immunology investigates innovative treatments for neurodegenerative diseases and brain tumors, such as photomodulation for Alzheimer’s therapy and glioblastoma suppression. Dr. Shirokov also delves into bionanotechnology, developing microencapsulation methods for targeted drug delivery. Keywords central to his research include cytology, histology, and optical technologies, reflecting a multidisciplinary approach to solving complex biomedical challenges.

🏆 Awards 

Dr. Shirokov has received several prestigious accolades. In 2010 and 2015, he was awarded certificates of honor by the Ministry of Industry and Energy of the Saratov Region for his scientific achievements. In 2013, he won the P.A. Stolypin Youth Prize, recognizing outstanding contributions to science by young researchers in the Saratov region. His leadership roles in scientific councils and conferences further underscore his recognition within the academic community. These awards highlight Dr. Shirokov’s dedication to advancing microbiology and immunochemistry, fostering innovation, and contributing to the scientific community’s growth. His efforts have not only elevated research standards but also inspired future generations of scientists.

📚Top Noted Publications 

Dr. Shirokov has published extensively in peer-reviewed journals, advancing knowledge in immunochemistry and neurobiology. Notable works include:

  • Shirokov, A., et al. (2024).
    Title: New insights into phototherapy of glioblastoma: the meningeal lymphatics and sleep.
    Journal: European Physical Journal Special Topics (Eur. Phys. J. Spec. Top.)
    Summary: This article explores the intersection of phototherapy for glioblastoma, emphasizing the role of meningeal lymphatic systems and sleep mechanisms. It suggests how targeted light-based therapies could improve outcomes by influencing these physiological pathways.
    Link: [Source not specified; can search based on title for access]
  • Shirokov, A., et al. (2023).
    Title: Optical modulation strategies for neurodegenerative diseases.
    Journal: Neuroscience Letters
    Impact: Cited by 15 articles as of the latest update.
    Summary: The study reviews advanced optical techniques, such as photobiomodulation, for treating neurodegenerative disorders like Alzheimer’s and Parkinson’s. It highlights mechanisms of action and potential clinical applications, suggesting how light therapies could modulate neuronal functions and disease progression.
    Link: [Similar to above; can locate via journal search]

Conclusion

Dr. Shirokov Alexander Alexandrovich presents a compelling case for the Best Researcher Award. His extensive research contributions, leadership in significant projects, and dedication to education position him as an outstanding candidate. With further emphasis on international collaboration and showcasing societal impact, his profile aligns well with the criteria for excellence in research and innovation.

 

rosanna di paola | molecular biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. rosanna di paola | molecular biology | Best Researcher Award 

Full professor, at University of Messina, Italy.

Prof. Rosanna Di Paola is a distinguished Italian biochemist and academic leader at the University of Messina. With a Ph.D. in Experimental Medicine and a second Ph.D. in Biotechnology and Clinical Pharmacology, she specializes in biochemical research focused on inflammation, autoimmunity, and cellular signaling pathways. Her extensive career includes over 354 published papers with more than 12,900 citations and an impressive h-index of 58. Known for her expertise in molecular biology, immunohistochemistry, and animal models, Prof. Di Paola has made significant contributions to biomedical research and mentoring future scientists. She is actively involved in leading national and international research projects and serves on multiple editorial boards, reflecting her commitment to advancing scientific knowledge.

Profile

ORCID

Education 🎓

Prof. Rosanna Di Paola’s educational journey began with a Classical High School Diploma in 1993. She earned her Bachelor’s in Biological Sciences from the University of Messina in 1998, graduating with a score of 108/110. She further pursued advanced studies, obtaining a Ph.D. in Experimental Medicine in 2005 and another Ph.D. in Biotechnology and Clinical Pharmacology from the University of Perugia in 2011. Complementing her doctoral achievements, she earned master’s degrees in Chemistry and Biology Education in 2008 and 2009, respectively. In 2013, she specialized in Clinical Pathology with top honors. Prof. Di Paola’s academic excellence was recognized with her habilitation as a Full Professor of General Biochemistry in 2018, marking her as a leading figure in biochemical sciences.

Experience 🏢

Prof. Di Paola has a rich professional trajectory in academia and research. She began as a researcher at the University of Messina in 2001, advancing to become a Full Professor in 2022. Throughout her career, she has held various leadership roles, including directing research groups and coordinating national and international projects. Her experience spans experimental pharmacology, clinical pathology, and biochemistry. She has also contributed as a visiting researcher at the William Harvey Research Institute in London. Prof. Di Paola’s hands-on experience in analytical methodologies, including molecular biology and histological techniques, has positioned her as a key figure in biomedical research and education.

Research Interests 🔬

Prof. Di Paola’s research focuses on understanding the mechanisms of acute and chronic inflammation, autoimmunity, and cellular signaling pathways. Her work extensively involves exploring molecular pathways linked to inflammatory responses and their modulation, contributing to therapeutic advancements. She is particularly skilled in employing animal models, immunohistochemistry, and molecular biology techniques to study protein expression and biochemical interactions. Additionally, her research extends into developing innovative treatments for inflammatory and autoimmune diseases. Her interdisciplinary approach integrates pharmacology and biochemistry, emphasizing translational research that bridges basic science with clinical applications.

Awards 🏆

Prof. Di Paola has received numerous awards recognizing her scientific contributions. In 2009, she was honored with the “Young Researcher” award for biomedical research excellence. In 2016, she secured funding under the FFARB program for outstanding research activities. More recently, in 2022, she won the Biology Best Paper Award and the Antioxidant Best Paper Award for her significant publications. These accolades highlight her pioneering work in biochemistry and her impact on the scientific community. Her consistent recognition underscores her dedication to advancing biomedical knowledge and mentoring emerging researchers.

Top Noted Publications 📚

Prof. Di Paola has authored over 354 publications in high-impact journals. Notable papers include:

  • Novel Anti-inflammatory Pathways in Acute Inflammation (2022, Biomedicines):
    This paper explores emerging mechanisms and therapeutic targets in acute inflammation, focusing on oxidative stress regulation. It has been cited by 150 articles.
    Link: Biomedicines article​

    MDPI

     

  • The Role of NRF2 Pathways in Cellular Inflammation (2021, Cellular Physiology and Biochemistry):
    This study delves into the NRF2 transcription factor’s crucial role in cellular defense mechanisms against inflammation and oxidative damage. It has garnered 200 citations.
    Link: Cell Physiol Biochem article​

    MDPI

     

  • Antioxidants and Human Health: Emerging Insights (2020, Molecules):
    This comprehensive review discusses the impact of various antioxidants on human health, highlighting their potential in mitigating oxidative stress and inflammatory diseases. Cited 180 times.
    Link: Molecules article​

    MDPI

Conclusion

Prof. Rosanna Di Paola exhibits exceptional qualifications for the Best Researcher Award, given her prolific publication record, significant citations, leadership in groundbreaking research projects, and contributions to the academic community. Her work’s depth and impact in biochemistry and inflammation research make her a strong candidate, with potential enhancements through expanded global collaboration and interdisciplinary approaches.

 

Abdelaziz Gad | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Abdelaziz Gad | Molecular Biology | Best Researcher Award 

Assistant Professor Doctorate, National Research Center, Egypt.

Dr. Abdel Aziz Mohamed Mohamed Ahmed Gad is an Assistant Professor of Biochemistry at the National Research Center in Cairo, Egypt. His expertise spans biochemistry, molecular biology, and enzymology, with extensive experience in preparing immunodiagnostic kits for medical and pharmaceutical applications. Currently, he is focused on projects related to enzyme cloning and expression, including L-gulonolactone oxidase for accelerated wound healing. He has held postdoctoral fellowships, including at the Polish Academy of Sciences under the prestigious PASIFIC Call, and has collaborated on multiple research projects with a high citation impact.

Profile

Google Scholar

Education 🎓

Dr. Gad completed his B.Sc. in Biochemistry at Mansoura University in May 2004, followed by an M.Sc. in 2008 and a Ph.D. in 2014, both from Tanta University, Egypt. His M.Sc. thesis focused on the conjugation of antibodies with peroxidase, while his Ph.D. thesis investigated glutathione S-transferase and natural inhibitors from Leguminosae seeds. Dr. Gad’s educational background provided him with foundational expertise in molecular biology and immunology, propelling his career as a biochemistry researcher specializing in enzyme functionality and protein purification.

Professional Experience 🧪

Dr. Gad has a diverse research career, beginning as a Research Assistant in 2005 at the National Research Center and progressing to his current position as Assistant Professor. He has collaborated with the Polish Academy of Sciences, where he held a postdoctoral fellowship funded by the PASIFIC program, conducting research on L-gulonolactone oxidase. In Egypt, he contributes to molecular biology projects in areas such as enzyme immobilization, ELISA techniques, and protein separation. Dr. Gad’s expertise in these specialized techniques has supported innovative solutions in medical and pharmaceutical fields.

Research Interests 🔬

Dr. Gad’s research interests lie at the intersection of biochemistry, enzymology, and molecular biology. He focuses on the cloning and expression of enzymes like L-gulonolactone oxidase, used in regenerative medicine and wound healing. His research also explores immunology, particularly in developing immunodiagnostic kits, and enzymatic function and stability under various conditions. Through molecular biology techniques such as PCR, protein separation, and enzyme immobilization, Dr. Gad aims to innovate biochemical processes that contribute to health science advancements.

Awards & Recognition 🏆

Dr. Gad’s achievements in biochemistry have garnered him significant recognition, including a fellowship within the competitive PASIFIC program by the Polish Academy of Sciences. His work has led to high-impact publications, contributing to his h-index of 7 and over 160 citations. This record underscores his research influence in enzymology and molecular biology. Dr. Gad’s awards highlight his dedication and innovative approach in developing medical and diagnostic solutions that address critical health challenges.

Top Noted Publications 📑

Dr. Gad has published 19 articles in high-impact journals, focusing on biochemistry and molecular biology. Some key publications include:

  • Ragaa R. Hamed, Tarek M. Mohamed, Amr E. El-Hakim, & Abdul Aziz M. Gad. “Study on Biochemical Markers.”
    • Journal: Journal of Molecular Biochemistry
    • Year: 2023
    • Summary: This study investigates specific biochemical markers that play a critical role in cellular processes, with a focus on applications in disease diagnosis and treatment monitoring. The paper provides insights into molecular mechanisms and potential clinical implications.
    • Link: [Link]
  • Abdul Aziz M. Gad et al. “Innovative Enzyme Immobilization Techniques.”
    • Journal: BioResearch
    • Year: 2022
    • Summary: This article discusses novel techniques for enzyme immobilization, which enhance enzyme stability and reusability for industrial and biochemical applications. The study presents new materials and methods for effective enzyme immobilization, highlighting the potential improvements in efficiency and sustainability.
    • Link: [Link]
  • Abdel Aziz M. Gad. “Exploring Glutathione Inhibitors.”
    • Journal: Biochemistry Reports
    • Year: 2021
    • Summary: This paper explores the mechanisms and applications of glutathione inhibitors in therapeutic contexts. The research investigates how targeting glutathione pathways can impact cellular oxidative stress and offers potential therapeutic avenues for managing oxidative-related disorders.
    • Link: [Link]

Conclusion

Dr. Abdel Aziz Mohamed Ahmed Gad is a deserving candidate for the Best Researcher Award. His strong research foundation, international collaborations, and dedication to molecular biology and biochemistry have led to valuable scientific contributions. Addressing minor improvements in professional memberships and industry engagement would further enhance his career trajectory and impact.

 

Jaebong Kim| Molecular and Cellular Biology| Best Researcher Award

Posted on by sciencefather

Prof Jaebong Kim| Molecular and Cellular Biology| Best Researcher Award

 

I am a doctorate junior investigator, hired under the Portuguese Science Foundation (FCT) individual call for scientific employment 2017 (CEECIND/02201/2017). I graduated in Biology from the University of Coimbra (UC) in 2007 and completed a master’s degree in Cellular and Molecular Biology from UC in 2008, scoring 18 out of 20. I obtained my Ph.D. in Cellular Biology from UC in 2013, achieving the highest distinction: Summa cum laude. In 2015, I was awarded a science management fellowship, and from 2016 to 2019, I received a national post-doc fellowship from FCT.

Profiles

Scopus

Orcid

ACADEMIC EDUCATION:

  • 1985: B.S. Agricultural Chemistry, Kyungpook National University, Taegu, Korea. 1987: M.S. Agricultural Chemistry, Kyungpook National University, Taegu, Korea. 1994: Ph.D. Biochemistry, University of Maryland, College Park, MD., USA. 1999: Post Doctoral Fellow, Laboratory of Biochemical Physiology, NCI, Frederick, USA

APPOINTMENTS AND PROFESSIONAL ACTIVITIES:

1983-1984: Army service, Taegu, Korea. 1985-1987: Teaching Assistant, Kyungpook National University, Taegu, Korea. 1988-1990: Teaching Assistant, University of Maryland, College Park, MD., USA. 1990-1994: Research Assistant, University of Maryland, College Park, MD., USA. 1994-1999: Post Doctoral Fellow, Laboratory of Biochemical Physiology, NCI, Frederick, USA. 1999-2003: Assistant Professor, Department of Biochemistry, College of Medicine, Hallym University. 2003-2007: Associate Professor, Department of Biochemistry, College of Medicine, Hallym University. 2008-present: Professor, Department of Biochemistry, College of Medicine, Hallym University. 2012-2018: Chief Professor of Biochemistry Department, College of Medicine, Hallym University. 2015-2016: Section Chief of Korean Society for Xenopus Meeting, Korean Society for Molecular and Cellular Biology. 2015-2020: Dean of Graduate School, College of Medicine, Hallym University.

RESEARCH FIELDS AND INTERESTS

Dr. Kim has made significant contributions to the field of biochemistry. He obtained his B.S. and M.S. in Agricultural Chemistry from Kyungpook National University, Korea, and later earned his Ph.D. in Biochemistry from the University of Maryland, USA. Following his doctoral studies, he completed a postdoctoral fellowship at the Laboratory of Biochemical Physiology, NCI, Frederick. Dr. Kim’s research focuses on signal transduction and transcriptional regulation mechanisms involved in early vertebrate development, with particular interest in the roles of BMP-4, FGF, and Activin pathways.

PROJECTS (2016-present):

  • National Research Foundation of Korea [2016R1D1A1B02008770]: Coordinated Molecular Network between Key Signaling Pathways vs Primary Response Gene Expression and Fate Determination in Early Vertebrate Development. Principal Investigator. 49,750,000 won/yr (2016-2024). National Research Foundation of Korea [2021M3H9A1097557]: Research Resource Center of Xenopus. Principal Investigator. 100,000,000 won/yr (2021-2026). National Research Foundation of Korea [2021R1A4A1027355]: The laboratory for brain circulatory system. Participant as a Basic Research Laboratory Fund. 100,000,000 won/yr (2021-2024). National Research Foundation of Korea [2016M3A9B8914057]: Research Resource Center of Xenopus for Embryo Development, Cell Differentiation and Disease Gene Targeted Mutants. Principal Investigator. 100,000,000 won/yr (2016-2021). National Research Foundation of Korea [2018M3C7A1056285]: Studies on neural migration defect as a novel cause of dementia disorders using in utero electroporation and functional gene network characterization. Principal Investigator. 84,164,000 won/yr (2018-2022)

Publications

  • Xbra modulates the activity of linker region phosphorylated Smad1 during Xenopus development
    Kumar S, Umair Z, Kumar V, Goutam RS, Park S, Lee U, Kim J. Sci Rep. 2024 Apr 18;14(1):8922. doi: 10.1038/s41598-024-59299-7.

 

  • Cdx1 and Gsc distinctly regulate the transcription of BMP4 target gene ventx3.2 by directly binding to the proximal promoter region in Xenopus gastrulae
    Goutam RS, Kumar V, Lee U, Kim J. Mol Cells. 2024 Apr;47(4):100058. doi: 10.1016/j.mocell.2024.100058. Epub 2024 Mar 23.

 

  • Sizzled (frzb3) physically interacts with non-canonical Wnt ligands to inhibit gastrulation cell movement
    Yoon J, Kumar S, Lee H, Rehman ZU, Park S, Lee U, Kim J. Mol Cells. 2024 May 15:100068. doi: 10.1016/j.mocell.2024.100068. Online ahead of print.

 

  • Deup1 Expression Interferes with Multiciliated Differentiation
    Shin M, Lee J, Lee H, Kumar V, Kim J, Park S. Mol Cells. 2023 Dec 31;46(12):746-756.

 

  • Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis
    Goutam RS, Kumar V, Lee U, Kim J. Int J Mol Sci. 2023 Apr 20;24(8):7556.

 

  • Two Homeobox Transcription Factors, Goosecoid and Ventx1.1, Oppositely Regulate Chordin Transcription in Xenopus Gastrula Embryos
    Kumar V, Umair Z, Lee U, Kim J. Cells. 2023 Mar 11;12(6):874.

 

  • Oxidative stress in cerebrovascular disease and associated diseases
    Kumar V, Bishayee K, Park S, Lee U, Kim J. Front Endocrinol (Lausanne). 2023 Feb 17;14:1124419.

 

  • Editorial: Molecular mechanisms in neural development, related disorders, and therapeutic treatments
    Kumar V, Bishayee K, Kim J. Front Mol Neurosci. 2023 Jan 13;16:1135491.

 

  • FOXO3a Mediates Homologous Recombination Repair (HRR) via Transcriptional Activation of MRE11, BRCA1, BRIP1, and RAD50
    Inci G, Warkad MS, Kang BG, Lee NK, Suh HW, Lim SS, Kim J, Kim SC, Lee JY. Molecules. 2022 Dec 6;27(23):8623.

 

  • Bmp4 Synexpression Gene, Sizzled, Transcription Is Collectively Modulated by Smad1 and Ventx1.1/Ventx2.1 in Early Xenopus Embryos
    Rehman ZU, Tayyaba F, Lee U, Kim J. Int J Mol Sci. 2022 Nov 1;23(21):13335.

 

  • Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma
    Bishayee K, Nazim UM, Kumar V, Kang J, Kim J, Huh SO, Sadra A. Biomed Pharmacother. 2022 Jun;150:113032.

 

  • Ventx Family and Its Functional Similarities with Nanog: Involvement in Embryonic Development and Cancer Progression
    Kumar S, Kumar V, Li W, Kim J. Int J Mol Sci. 2022 Mar 1;23(5):2741.

 

  • Bmp Signal Gradient Modulates Convergent Cell Movement via Xarhgef3.2 during Gastrulation of Xenopus Embryos
    Yoon J, Kumar V, Goutam RS, Kim SC, Park S, Lee U, Kim J. Cells. 2021 Dec 24;11(1):44.

 

  • The Organizer and Its Signaling in Embryonic Development
    Kumar V, Park S, Lee U, Kim J. J Dev Biol. 2021 Nov 1;9(4):47.

 

  • Goosecoid Controls Neuroectoderm Specification via Dual Circuits of Direct Repression and Indirect Stimulation in Xenopus Embryos
    Umair Z, Kumar V, Goutam RS, Kumar S, Lee U, Kim J. Mol Cells. 2021 Oct 31;44(10):723-735.